# Safety and Efficacy of an Antioxidant-rich Multivitamin Supplement in Cystic Fibrosis

> **NCT01018303** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 17 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DIETARY_SUPPLEMENT:** AquADEK

## Key facts

- **NCT ID:** NCT01018303
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-06
- **Final completion:** 2009-11
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2012-10-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01018303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01018303, "Safety and Efficacy of an Antioxidant-rich Multivitamin Supplement in Cystic Fibrosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01018303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*